BIIB FY 2021 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena

BIIBBiogen Inc.

$28B

FY 2021 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$11.0B-18.3% YoY

Gross Profit

$8.9B80.8% margin

Operating Income

$2.8B25.4% margin

Net Income

$1.6B14.2% margin

EPS (Diluted)

$10.40

Cash Flow

Operating Cash Flow

$3.6B

Free Cash Flow

$3.4B

Stock-Based Comp.

$239M

Balance Sheet

Total Assets

$23.9B

Total Liabilities

$12.9B

Stockholders' Equity

$10.9B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.0B	$13.4B	-18.3%
Gross Profit	$8.9B	$11.6B	-23.8%
Operating Income	$2.8B	$4.6B	-39.2%
Net Income	$1.6B	$4.0B	-61.1%